With five products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
- BioMarin to Host First Quarter 2014 Financial Results Conference Call and Webcast on Thursday, May 1 at 5:00 p.m. ET... MORE >
- FDA Extends Market Exclusivity Six Months for BioMarin's Rare Disease Therapy KUVAN(R) (sapropterin dihydrochloride) Powder for Oral Solution and Tablets... MORE >
- BioMarin Appoints Pioneer in Personalized Medicine, Dennis J. Slamon, M.D., Ph.D., to Board of Directors... MORE >
- /> Click here to learn more about VIMIZIM (elosulfase alfa), including full prescribing information and boxed warning.
- /> MorquioAnswers.com is an educational site for health care professionals to learn more about Morquio A diagnosis and management.
- Morquiosity.com is designed to empower the Morquio A community through education and support.
- PKU.com is a comprehensive online resource for the PKU community.